Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Duchenne Muscular DystrophyFascioscapulohumeral Muscular DystrophyMyotonic Dystrophy 1Charcot-Marie-ToothCentronuclear MyopathyCongenital Muscular Dystrophy
Interventions
DEVICE

ActiMyo/Syde

"The two watches can be worn as wristwatch or placed near the ankle and on the wheelchair.~* Patients with DMD or FKRP mutation will wear the ActiMyo°/Syde° during 3 months at baseline and then for one month every 3 months.~* Patient with FSHD, DM1, CMT, CNM will wear the ActiMyo°/Syde° will wear the ActiMyo/Syde° during 3 months at baseline and then for one month every 6 months.~* Control subjects \>4years will wear the ActiMyo°/Syde° during one month after inclusion and during one other month 11 months after inclusion.~* Control subjects \<4years will wear the ActiMyo°/Syde° during one month after inclusion and during one other month every 6months after inclusion."

Trial Locations (8)

4000

RECRUITING

CHR de la Citadelle, Liège

Unknown

ACTIVE_NOT_RECRUITING

Fakultni nemocnice v Motole, Prague

ACTIVE_NOT_RECRUITING

Galaa Military Medical Complex, Cairo

ACTIVE_NOT_RECRUITING

Semmelweis University 2nd Department of Paediatrics, Budapest

ACTIVE_NOT_RECRUITING

Warsaw Medical University Hospital, Department of Neurology, Warsaw

ACTIVE_NOT_RECRUITING

"National Clinical Hospital for Children Neurohabilitation Dr Nicolae Robanescu", Bucharest

ACTIVE_NOT_RECRUITING

University Children's Hospital, Department for Pediatric Neurology, Ljubljana

041914

RECRUITING

"Pediatric Neurology Clinic, Clinical Hospital of Psychiatry Prof. Dr. Al. Obregia", Bucharest

All Listed Sponsors
collaborator

SYSNAV

INDUSTRY

lead

Centre Hospitalier Universitaire de Liege

OTHER